Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Creative Biolabs supports pre-clinical in vitro immunological analysis of vaccines. We provide complete immunogenicity assessment of vaccine products, immunotoxicity assessment, coverage immunoassays, and cell-based cellular immune functional assays in GLP-certified laboratories.
Our vaccine solutions also include analytics development, efficacy monitoring, project management, and data management to meet your development needs throughout the vaccine development life cycle. We can work with you to develop and validate customized assays to meet your drug development goals.
Immunogenicity refers to the ability of an antigen to induce an immune response. Creative Biolabs has the expertise and resources to develop and validate methods and perform sample analysis to help you fully understand the discovery of vaccine products and pre-clinical immunogenicity.
Assay Types
Platform/Analysis Format
Creative Biolabs immunology team provides you with a fully integrated service to assess the potential of vaccines as immunosuppressants or immunostimulants and to determine immunological endpoints and antigen-induced changes in cell function.
Creative Biolabs is able to predict potential immunotoxicology during pre-clinical development. By working with you and understanding your goals, we can tailor testing methods to suit your needs. Our analysis uses whole blood and PBMC, but also uses purified populations (e.g., T cells, dendritic cells, macrophages, platelets, and endothelial cells) that allow us to monitor functional changes.
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
